Table 6.
Group | n | Liver; µg Fe/mg wet tissue (± SD) |
Spleen; µg Fe/mg wet tissue (± SD) |
---|---|---|---|
S0 | 3 | 0.6 (0.6) | 0.7 (0.1) |
SH | 4 | 0.6 (0.6) | 0.9 (0.2) |
LL | 3 | 6.8 (0.4) | 3.37 (1.8) |
LH | 3 | 5.3 (2.3) | 7.2 (7.7) |
H0 | 3 | 16.3 (11.8) | 9.1 (7.8) |
HL | 4 | 20.8 (13.3) | 10.9 (7.7) |
HH | 3 | 18.9 (26.4) | 46.3 (79.0) |
Iron concentrations were measured by inductively coupled plasma mass spectrometry. The first letter of each group designation indicates the dose of nanoparticles injected: saline (S), low-dose (L) or high-dose (H) superparamagnetic iron oxide. The second letter of each group designation indicates the field strength for alternating magnetic field exposure: zero (0), low (L) or high (H) field.
SD: Standard deviation.